Catalyst Wire Dossier Catalyst Wire Dossier

Xopenex (Levalbuterol)

Levalbuterol · Sunovion Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Xopenex (Levalbuterol), covering 2012-02-22 to 2012-02-22. Get the full timeline:

Most recent: Clinical Trial Update: Dose Response Study of Levalbuterol in the Prevention of Exercise Induced Bronchoconstriction Compared to Racemic Albuterol [Phase 3]

See pricing